
Reticuline
CAS No. 485-19-8
Reticuline ( —— )
产品货号. M21802 CAS No. 485-19-8
Reticuline 是从山苍子中分离出来的,通过 JAK2/STAT3 和 NF-κB 信号通路发挥抗炎作用。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥8982 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Reticuline
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Reticuline 是从山苍子中分离出来的,通过 JAK2/STAT3 和 NF-κB 信号通路发挥抗炎作用。
-
产品描述Reticuline, isolated from Litsea cubeba, shows anti-inflammatory effects through JAK2/STAT3 and NF-κB signaling pathways. Reticuline inhibits mRNA expressions of TNF-α, and IL-6 and reduces the phosphorylation levels of JAK2 and STAT3.
-
体外实验Reticuline (3 μM, 30 μM, 300 μM, 900 μM and 1.5 mM) inhibits in a concentration-dependent manner the contractions induced by Phenylephrine (1 μM), KCl (80 mM) and KCl (30 mM), (IC50=40±10, 240±40 and 300±40 μM, respectively) in isolated rat aortic rings with intact endothelium.Reticuline (3 μM, 30 μM, 300 μM, 900 μM and 1.5 mM) antagonizes CaCl2-induced contractions, and also inhibits the intracellular calcium dependent transient contractions induced by Norepinephrine (1μM), but not those induced by Caffeine (20 mM).
-
体内实验Reticuline (5, 10 and 20 mg/kg, i. v., randomly) injections produced an intense hypotension in normotensive rats. The hypotensive effect of Reticuline is probably due to a peripheral vasodilation in consequence of: 1) muscarinic stimulation and NOS activation in the vascular endothelium, 2) voltage-dependent Ca2+ channel blockade and/or 3) inhibition of Ca2+ release from norepinephrine-sensitive intracellular stores.
-
同义词——
-
通路Angiogenesis
-
靶点JAK
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number485-19-8
-
分子量329.39
-
分子式C??H??NO?
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (303.59 mM)
-
SMILESOC1=CC2=C(C=C1OC)CCN(C)[C@H]2CC3=CC=C(OC)C(O)=C3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Yang X, et al. Anti-Inflammatory Effects of Boldine and Reticuline Isolated from Litsea cubeba through JAK2/STAT3 and NF-κB Signaling Pathways. Planta Med. 2018 Jan;84(1):20-25.
产品手册




关联产品
-
WYE-151650
WYE-151650 是一种新型有效的选择性 JAK3 抑制剂,IC50 为 0.8 nM,对 JAK-1、JAK-2 和 Tyk-2 的选择性分别为 36、14 和 34 倍。
-
JAK3i
JAK3i 是一种选择性共价 JAK3 激酶抑制剂,IC50 为 0.43 nM。
-
Fedratinib hydrochlo...
Fedratinib 盐酸盐水合物是一种有效的、选择性的、ATP 竞争性的、口服活性的 JAK2 抑制剂。